A detailed history of Mai Capital Management transactions in Danaher Corp stock. As of the latest transaction made, Mai Capital Management holds 51,206 shares of DHR stock, worth $11.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
51,206
Previous 52,894 3.19%
Holding current value
$11.8 Million
Previous $13.2 Million 7.71%
% of portfolio
0.14%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$239.25 - $280.76 $403,854 - $473,922
-1,688 Reduced 3.19%
51,206 $14.2 Million
Q2 2024

Aug 12, 2024

BUY
$235.51 - $267.98 $872,800 - $993,133
3,706 Added 7.53%
52,894 $13.2 Million
Q1 2024

May 08, 2024

BUY
$224.58 - $256.19 $770,983 - $879,500
3,433 Added 7.5%
49,188 $12.3 Million
Q4 2023

Feb 09, 2024

SELL
$185.1 - $233.13 $7.59 Million - $9.55 Million
-40,985 Reduced 47.25%
45,755 $10.6 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $1.11 Million - $1.26 Million
4,754 Added 5.8%
86,740 $21.5 Million
Q2 2023

Aug 02, 2023

BUY
$224.99 - $256.14 $995,580 - $1.13 Million
4,425 Added 5.71%
81,986 $19.7 Million
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $3,116 - $3,601
13 Added 0.02%
77,561 $19.5 Million
Q4 2022

Feb 09, 2023

BUY
$241.42 - $282.29 $390,617 - $456,745
1,618 Added 2.13%
77,548 $20.6 Million
Q3 2022

Nov 15, 2022

BUY
$247.06 - $1507.4 $2.07 Million - $12.7 Million
8,397 Added 12.43%
75,930 $19.6 Million
Q2 2022

Jul 19, 2022

BUY
$237.11 - $299.66 $3.15 Million - $3.98 Million
13,278 Added 24.47%
67,533 $17.1 Million
Q1 2022

May 10, 2022

BUY
$257.27 - $315.76 $7.76 Million - $9.53 Million
30,172 Added 125.28%
54,255 $15.9 Million
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $510,847 - $575,438
-1,749 Reduced 6.77%
24,083 $7.92 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $86,562 - $105,712
318 Added 1.25%
25,832 $7.86 Million
Q2 2021

Jul 19, 2021

SELL
$225.08 - $271.69 $200,996 - $242,619
-893 Reduced 3.38%
25,514 $6.85 Million
Q1 2021

May 10, 2021

SELL
$212.38 - $245.9 $293,933 - $340,325
-1,384 Reduced 4.98%
26,407 $5.94 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $228,650 - $264,114
-1,076 Reduced 3.73%
27,791 $6.17 Million
Q3 2020

Oct 26, 2020

SELL
$177.16 - $215.33 $801,471 - $974,152
-4,524 Reduced 13.55%
28,867 $6.22 Million
Q2 2020

Jul 27, 2020

BUY
$128.7 - $176.83 $517,116 - $710,502
4,018 Added 13.68%
33,391 $5.91 Million
Q1 2020

Apr 16, 2020

BUY
$121.39 - $169.05 $16,509 - $22,990
136 Added 0.47%
29,373 $4.07 Million
Q4 2019

Feb 03, 2020

BUY
$133.47 - $153.48 $136,406 - $156,856
1,022 Added 3.62%
29,237 $4.49 Million
Q3 2019

Oct 29, 2019

BUY
$135.4 - $146.47 $611,737 - $661,751
4,518 Added 19.07%
28,215 $4.08 Million
Q2 2019

Aug 15, 2019

BUY
$124.88 - $143.73 $883,401 - $1.02 Million
7,074 Added 42.56%
23,697 $3.39 Million
Q1 2019

Apr 29, 2019

BUY
$97.62 - $132.29 $1,854 - $2,513
19 Added 0.11%
16,623 $2.2 Million
Q4 2018

Jan 30, 2019

BUY
$94.85 - $109.54 $64,972 - $75,034
685 Added 4.3%
16,604 $1.71 Million
Q3 2018

Oct 12, 2018

SELL
$98.13 - $108.9 $20,803 - $23,086
-212 Reduced 1.31%
15,919 $1.73 Million
Q2 2018

Aug 16, 2018

SELL
$96.1 - $103.24 $17,201 - $18,479
-179 Reduced 1.1%
16,131 $1.59 Million
Q1 2018

Apr 17, 2018

SELL
$92.16 - $103.8 $56,309 - $63,421
-611 Reduced 3.61%
16,310 $1.6 Million
Q4 2017

Jan 30, 2018

BUY
$85.26 - $94.62 $5,115 - $5,677
60 Added 0.36%
16,921 $1.57 Million
Q3 2017

Oct 12, 2017

SELL
$79.29 - $88.45 $1,823 - $2,034
-23 Reduced 0.14%
16,861 $1.45 Million
Q2 2017

Aug 07, 2017

BUY
N/A
16,884
16,884 $1.43 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.